Cardiotoxicity induced by the combinatorial treatment based on the immune checkpoint inhibitor pembrolizumab associated to trastuzumab
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
29 More presentations in this session
Doctor V. Aengevaeren (Nijmegen, NL)
Doctor T. Infante (Naples, IT)
Doctor M. Anguita Sanchez (Cordoba, ES)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
